HER2-positive Metastatic and Triple-negative Cancer Treatments

Chapter 2

In this video, Ruth M. O'Regan, MD, division head of hematology/oncology at the University of Wisconsin Carbone Cancer Center, discusses emerging treatments for patients with HER2-positive, metastatic breast cancer, as well as those for triple-negative breast cancer. CDK inhibitors and everolimus are among the treatments used for patients with HER2-positive disease, though other drugs are being studied. Dr O’Regan also discusses current research on triple-negative cancer.

Chapter 1

2016 SABCS: Clinical Insights for Breast Cancer Treatment

In this video, Ruth M. O'Regan, MD, division head of hematology/oncology at the University of Wisconsin Carbone Cancer Center, discusses the research most likely to have a clinical impact presented at the 2016 San Antonio Breast Cancer Symposium (SABCS). Highlights include practice-changing findings from 3 trials of endocrine therapy, as well as a study about the use of everolimus with fulvestrant among patients with breast cancer.

Chapter 3

Treatment-related Neuropathy and Breast Cancer Treatment

In this video, Ruth M. O'Regan, MD, division head of hematology/oncology at the University of Wisconsin Carbone Cancer Center, discusses treatment-related neuropathy, which is a common adverse event among patients being treated for breast cancer. Dr O’Regan discusses options for mitigating this side effect, which can be caused by multiple frequently-used treatments.

Chapter 4

Emerging Medicines in Breast Cancer Treatment

In this video, Ruth M. O'Regan, MD, division head of hematology/oncology at the University of Wisconsin Carbone Cancer Center, discusses emerging treatments that are being used for patients with breast cancer, including precision medicine for individualizing cancer treatment, as well as liquid biopsies.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs